N-acetylcysteine in Alcohol Dependence
Completed · Phase 1/Phase 2 · Has a placebo group
Conditions studied: Alcoholism
In brief
The present study is designed to find out if N-acetylcysteine works in reducing alcohol drinking and craving.
Key facts
- Study ID
- NCT00568087
- Run by
- Minneapolis Veterans Affairs Medical Center
- People needed
- 46
- Starts
- 2007-12-01
- Expected to finish
- 2009-08-01
- Last updated by the study team
- 2020-03-18
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- age 18 - 65
- alcohol dependence by DSM-IV
- heavy drinking at least 4 times in the past month
- able to provide informed consent
You may not qualify if…
- current drug abuse or dependence by DSM-IV criteria (except nicotine or cannabis)
- current psychotic disorders, bipolar disorders, or cognitive disorders
- current suicidal or homicidal ideation
- positive illicit drug screen (except cannabis)
- Clinical Institute Withdrawal Assessment for Alcohol, Revised >15
- initiation of individual therapy or counseling in the past 3 months
- changes in doses of psychiatric medications in the past 3 months
- clinically unstable cardiac, hepatic, renal, neurologic, or pulmonary disease
- current use of naltrexone, disulfiram or acamprosate
- pregnant or nursing women, or inadequate birth control methods in women of childbearing potential
Where it is running
- Minneapolis VA Medical Center — Minneapolis, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.